Tandem Diabetes Care (TNDM) Cash from Financing Activities (2016 - 2025)
Historic Cash from Financing Activities for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to -$1.6 million.
- Tandem Diabetes Care's Cash from Financing Activities rose 6525.78% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.7 million, marking a year-over-year decrease of 60298.32%. This contributed to the annual value of $8.4 million for FY2024, which is 10342.82% up from last year.
- As of Q3 2025, Tandem Diabetes Care's Cash from Financing Activities stood at -$1.6 million, which was up 6525.78% from -$39.7 million recorded in Q2 2025.
- In the past 5 years, Tandem Diabetes Care's Cash from Financing Activities registered a high of $18.8 million during Q3 2021, and its lowest value of -$39.7 million during Q2 2025.
- Moreover, its 5-year median value for Cash from Financing Activities was $2.6 million (2023), whereas its average is $1.9 million.
- Per our database at Business Quant, Tandem Diabetes Care's Cash from Financing Activities skyrocketed by 261127.54% in 2024 and then tumbled by 122288.47% in 2025.
- Quarter analysis of 5 years shows Tandem Diabetes Care's Cash from Financing Activities stood at $15.9 million in 2021, then tumbled by 61.6% to $6.1 million in 2022, then crashed by 57.1% to $2.6 million in 2023, then decreased by 12.04% to $2.3 million in 2024, then crashed by 168.2% to -$1.6 million in 2025.
- Its last three reported values are -$1.6 million in Q3 2025, -$39.7 million for Q2 2025, and -$4.7 million during Q1 2025.